This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This study aims to compare cytotoxicity and induced apoptosis of a new bioceramic cement containing different concentrations of simvastatin on stem cells from human exfoliated deciduous teeth (SHED).
This research was an in vitro study. To evaluate the cytotoxicity and induced apoptosis of the bioceramic cement containing different concentrations of simvastatin, the SHED were exposed to the cement during 1, 3, and 7 days. Pure bioceramic cement and pure simvastatin with concentrations of 1, 0.1, and 0.01 μM were also tested to evaluate the possible synergic effect. Mineral trioxide aggregate (MTA) as the gold standard of pulp dressing materials was compared. MTT assay and Annexin V assay were used to evaluate cytotoxicity and induced apoptosis, respectively. The data were analyzed using ANOVA and Tukey post hoc tests at the significance level of 0.05.
During 7 days, MTA, bioceramic cement, simvastatin 0.1 and 0.01 μM, and bioceramic cement containing 0.1 and 0.01 μM simvastatin increased (P < 0.05) and simvastatin with concentration of 1 μM decreased the cell viability (P < 0.05). Except for MTA and bioceramic cement containing 0.1 and 0.01 μM simvastatin, all other compounds induced apoptosis within 7 days (P < 0.05).
After 7 days, the viability of the SHED in the presence of a new bioceramic cement containing 0.1 and 0.01 μM simvastatin was not compromised. Moreover, this cement showed superior results than MTA and provided an environment for cell proliferation. This finding appears to be due to the pharmacological effects of low concentrations of simvastatin.
Dental caries is the most common chronic infectious disease of childhood. Despite significant advances in preventive dentistry, many children still suffer from the disease and its consequences including pain, infection, chewing and eating disorders, space loss, psychological problems, and missing school hours.
Pulpotomy is the most common pulp treatment method in primary dentition with the ultimate goal of maintaining the health and integrity of the oral and dental structures.
Pharmacologic and nonpharmacologic techniques of pulpotomy are categorized as devitalizing (e.g., formocresol, electrosurgery, laser), preserving (e.g., ferric sulfate, sodium hypochlorite), and regenerating (e.g., calcium hydroxide, calcium silicate-based cements) based on their effect on the remaining radicular pulp.
Ideally, the materials used for pulpotomy should have antibacterial activity and easy manipulation, provide a tight seal, be affordable and not interfere with physiological root resorption.
A material with all these properties has not yet been manufactured, and studies in this field have been continued since the 1900s with the introduction of Buckley formocresol.
Although calcium silicate-based cements (e.g., mineral trioxide aggregate [MTA] and CEM Cement) have revealed promising results in several clinical studies,
To overcome these disadvantages, a series of studies are designed to evaluate the biological properties of a new bioceramic cement containing simvastatin on stem cells from human exfoliated deciduous teeth (SHED).
The new hydroxyapatite-based bioceramic cement containing tricalcium silicate, silicon hydroxyapatite, and strontium hydroxyapatite has been prepared and introduced in 2019 at the Dental Materials Research center, Mashhad University of Medical Sciences. Studies on this new material have been very limited.
In recent years, there has been a tendency toward the use of simvastatin in dentistry.
As the first step, we aimed to determine if adding simvastatin to the bioceramic cement will affect its biological properties on SHED. Hence, the aim of this in vitro study was to compare the cytotoxicity and induced apoptosis of a new bioceramic cement containing different concentrations of simvastatin on SHED by MTT and Annexin V assays, respectively.
This in vitro study was conducted in August 2020 in the Dental Research Center of Mashhad University of Medical Sciences with the ethics committee registration code IR.MUMS.DENTISTRY.REC.1399.005.
Preparation of bioceramic cement
Bioceramic cement (Mashhad University of Medical Sciences, Iran) containing 50% by weight of tricalcium silicate/dicalcium silicate, 25% by weight of strontium-doped hydroxyapatite, and 25% by weight of silicon-doped hydroxyapatite has been prepared.
Silicon-hydroxyapatite was prepared as described through a sol-gel method in an aqueous-alcoholic medium, assuming the substitution of silicate ions instead of phosphate. For this purpose, 0.02 mol of tetraethyl orthosilicate (TEOS) in 100 cc of water/ethanol solution was first placed on a magnetic stirrer to complete the hydrolysis. Then, 0.28 mol of sodium dihydrogen phosphate salt was dissolved in 100 cc of deionized distilled water and added to the container containing TEOS. The pH of the solution was adjusted to 10 using normal sodium hydroxide. As a source of calcium ions, 0.5 mol of calcium chloride in 200 cc of water was used. So that the final molar ratio is established:
[Ca + 2]/[P + Si] = 1.67
Calcium chloride solution was gradually added to the solution containing phosphate and silica over 1 h. The pH of the reaction vessel was fixed at 10 using 1N sodium hydroxide. The product was placed on a stirrer at 80°C for 12 h. After 12 h, the liquid phase was separated using a centrifuge at 4000 rpm, and the resulting solid was dried at ambient temperature and sintered at 800°C for 10 h with a temperature gradient of 10°C/min.
The synthesis of strontium-hydroxyapatite was performed by the sol-gel method in an aqueous medium, assuming the substitution of strontium ions instead of calcium. For this purpose, 0.05 mol of strontium chloride and 0.45 mol of calcium chloride were dissolved in 200cc of deionized distilled water. Then, 0.3 mol of sodium dihydrogen phosphate salt was dissolved in 200cc of deionized distilled water. The pH of the solution was adjusted to 10 using 1N sodium hydroxide. Hence that the final molar ratio is established:
[Ca + 2 + Sr + 2]/[Pi] = 1.67
Strontium chloride/calcium chloride solution was gradually added to the phosphate solution over 1 h using a decanter. Using the pH meter, the pH of the reaction vessel was fixed at 10 using 1N sodium hydroxide. The resulting material was placed on a stirrer at 25°C for 72 h. After 72 h, the liquid phase was separated using a centrifuge at 4000 rpm, and the resulting solid was dried at ambient temperature and sintered at 800°C for 10 h with a temperature gradient of 10°C/min.
Calcium silicate was prepared using a sol-gel method in an aqueous-alcoholic medium. First, 0.5 mol TEOS was mixed in 200 cc of deionized-distilled water and nitric acid (as a catalyst) to complete hydrolysis. Then, 1.5 mol of calcium nitrate was added and stirred at 80°C until gel formation. The resulting gel was dried in an oven at 120°C, and the white powder was placed at 1200°C for 10 h. After heat treatment, the mass of the resulting ceramic was ground by a mortar and ball-milling operation for 24 h in a container containing acetone and glass balls with a diameter of 3 mm. After drying, the resulting powder was sieved with a sieve size of 37 microns.
The synthesized ceramic was characterized by X-ray diffraction (XRD), (X' Pert PW 3040/60, Philips, The Netherlands) at 2θ = 20-80°. The morphology of ceramic particles was studied using scanning electron microscopy.
To add simvastatin to bioceramic cement, first concentrations of 0.01, 0.1, and 1 μM simvastatin (Sigma-Aldrich, Germany) were prepared in the liquid phase. According to the molecular weight of simvastatin (418.56 g/mol), 100 mg of this substance was dissolved in 50 ml of distilled water and uniformly mixed to form a suspension with a concentration of 1000 μM. By diluting this solution, 1, 0.1, and 0.01 μM solutions were obtained. Each of the concentrations was mixed with the bioceramic cement with 1:1 weight ratios to obtain a paste consistency. To prepare pure bioceramic cement, cement powder and distilled water were mixed with a 1:1 weight ratio.
Each compound was poured into tablet-shaped plastic molds and placed in an incubator (LEEC, England) with 100% humidity and 37°C for completion of the setting reaction. Then, the tablets were transferred to the cell culture laboratory for cellular experiments. The tablets were placed in the culture medium for 48 h to exchange particles.
Culture medium preparation
To prepare the culture medium, an appropriate amount of D-MEM (Modified Eagles Medium Dulbeccos) filtered medium was used. The acidity of the culture medium was adjusted by hydrochloric acid and NaOH in the range of 7.4. Then a combination of 10% fetal calf serum and 1% antibiotics including 1000 U/ml penicillin and 10 mg/ml streptomycin in a proportion of 1:10 was added. The solution was stored in a sterile container in the refrigerator until use.
Cell preparation
The cells were cultured and passaged to reach a sufficient number. The SHED were cultured in the logarithmic phase of proliferation in the culture medium. These cells were incubated in 5% CO
For cell passage, the outdated culture medium was removed, and 2 mm of trypsin enzyme was poured on the cells. Incubation was performed for 5 min at 37°C. Then, 2 ml of culture medium containing 10% FBS (Gibco, USA) was added to the plate to stop the lethal activity of trypsin. The cells isolated from the bottom of the plate were transferred to a 15 ml sterile tube and centrifuged for 5 min at 1900 rpm. After washing the cells with PBS (Phosphate Buffered Saline), a few milliliters of fresh culture medium were added to the cell sediment at the bottom of the centrifuge tube and vortexed (Velp, Iran). Then, 2 ml of the resulting suspension (at a concentration of 10
Cell viability by MTT assay
MTT is a standard laboratory test to determine the cytotoxicity of various substances. This test is based on mitochondrial activity. Linear changes in mitochondrial activity may be associated with an increase or decrease in the number of living cells. In this test, cells break the yellow tetrazolium ring by mitochondrial dehydrogenase, producing NADH and NADPH, leading to the formation of a purple precipitate of formazan. The precipitate is then dissolved in isopropanol or dimethyl sulfoxide. Cells that are not alive lack such activity and do not cause discoloration. Thus, the intensity of the purple color indicates the number of viable cells or, in other words, cell proliferation. The color intensity at 570 nm is measured by the ELISA plate reader and is directly related to the number of cells with metabolic activity.
In this study, MTT was performed following the ISO/EN-109935
[INLINE:1]
Induced apoptosis by Annexin V
Annexin V is an available test to quantify the extent of apoptosis and cellular necrosis affected by the stimulus. The surface of healthy cells is made up of lipids that are asymmetrically present on the inner and outer layers of the cell membrane. One of these lipids, called phosphatidylserine, is usually confined to the inner layer of the membrane and is located only in the vicinity of the cytoplasm. During apoptosis, this lipid asymmetry changes, and phosphatidylserine will be located in the outer layer of the membrane, as well. Annexin V is a calcium-binding protein that binds to this lipid, and its fluorescent form can be used to detect phosphatidylserine in the outer layer of the membrane of apoptotic cells. In addition, Annexin V can stain necrotic cells. In this case, the cells lack the membrane integrity that gives this protein access to all areas.
The “FITC Annexin V Apoptosis Detection Kit with PI” (Biolegend, 640914, USA) was used to evaluate the extent of induced apoptosis, genotoxicity, and DNA damage. The cells were incubated in 48-well plates with 10
Statistical analysis
Cell viability and apoptosis, evaluated by MTT assay and Annexin V, are presented as the mean percentage ± standard deviation. Due to biological experiments and triple replications of each of target concentration, the sample size is not considered in such studies.
The results of the MTT assay and Annexin V biological tests were analyzed by analysis of variance (ANOVA). As the statistical significance for analyzed variables was determined, the Tukey-post-hoc test was performed. Analysis was conducted by GraphPad Prism software, version 9 (GraphPad, USA) at the significance level of 0.05 (P < 0.05).
Electron microscopy images showed that a dense hexagonal crystal structure with sub-micron dimensions resembling calcium silicate was formed in the calcium silicate sample. In two examples of apatite ceramics, hexagonal crystals similar to the structure of apatite are evident. In the silicon hydroxyapatite sample, the crystals are elongated, and in the strontium hydroxyapatite sample, plate-shaped crystals with larger dimensions are observed
scanning electron microscope view. (a) Calcium silicate, (b) Silicon-dopped hydroxyapatite, (c) strontium-dopped hydroxyapatite, (d) set-cement
Analysis of the XRD pattern confirmed the formation of the apatite structure in the presence of silicon and strontium ions and the replacement of the strontium and silicon ions in the hydroxyapatite structure. The XRD model for silicate composition also showed that the reaction product was a mixture of dicalcium silicate and tricalcium silicate
X-ray diffraction pattern. (a) Calcium silicate, (b) Silicon-dopped hydroxyapatite, (c) strontium-dopped hydroxyapatite, (d) set-cement
Cell viability by MTT assay
The findings of the MTT assay showed that during 7 days, the percentage of viable cells increased in a culture medium containing bioceramic cement. Among simvastatin concentrations, SIM 0.01 caused the maximum percentage of viable cells over 7 days (101%). Only in this concentration, the percentage of viable cells increased over time. Furthermore, along with the decreased concentration of simvastatin, the percentage of viable cells has increased. On day 7, this difference is statistically significant for all three concentrations compared to each other. It is also evident that over 7 days, CEM/SIM 0.01 caused the maximum percentage of viable cells in the culture medium with bioceramic cement containing simvastatin (108%). It is noteworthy that unlike CEM/SIM 1, CEM/SIM 0.01 and CEM/SIM 0.1 increase the percentage of viable cells over time. For comparison with the gold standard, it could be noted that after 7 days, the percentage of viable cells in the culture medium containing bioceramic cement, SIM 0.01, CEM/SIM 0.01, and CEM/SIM 0.1 was higher compared to MTA. This superiority is statistically significant for the bioceramic cement with concentration of 0.01 (P < 0.0001), CEM/SIM 0.1 (P = 0.004) and CEM/SIM 0.01 (P < 0.0001).
Adding simvastatin to the bioceramic cement resulted in different measures compared to each of them alone. It could be noted that after 7 days, CEM/SIM 0.1 caused a higher percentage of viable cells than the bioceramic cement (P < 0.9) and SIM 0.1 (P < 0.0001). Furthermore, after seven days, CEM/SIM 0.01 caused in higher percentage of viable cells than the bioceramic cement (P = 0.2) and SIM 0.01 (P < 0.0001).
MTT assay comparison graph. CEM: Bioceramic cement with full concentration; SIM 1: Simvastatin with concentration of 1 μM; SIM 0.1: Simvastatin with concentration of 0.1 μM; SIM 0.01: Simvastatin with concentration of 0.01 μM; CEM/SIM 1: Bioceramic cement containing simvastatin 1 μM; CEM/SIM 0.1: Bioceramic cement containing simvastatin 0.1 μM; CEM/SIM 0.01: Bioceramic cement containing simvastatin 0.01 μM
Cell apoptosis by Annexin V
The results of Annexin V show that the percentage of apoptotic cells in the culture medium containing bioceramic cement increased during 7 days. SIM 0.01 caused the minimum percentage of apoptotic cells among different concentrations of this substance (14%), and in all three concentrations, the percentage of apoptotic cells increased over time. Furthermore, along with decreased concentrations, the percentage of apoptotic cells decreased. This decrease on day 7 was statistically significant for all three concentrations compared to each other (P < 0.0001). By adding simvastatin to the bioceramic cement, CEM/SIM 0.01 caused the minimum percentage of apoptotic after 7 days (9%). It is noteworthy that the percentage of apoptotic cells in the culture medium with bioceramic cement containing all three concentrations of simvastatin increased over time. For comparison with the gold standard, it could be noted that the percentage of apoptotic cells in the culture medium containing MTA increased over 7 days, but the measures were lower than all other substances, and this difference was statistically significant for almost all comparisons (except for CEM/SIM 0.01).
As shown for cell viability, adding simvastatin to the bioceramic cement resulted in different measures compared to each of them alone. After 7 days, the percentage of apoptotic cells in the culture medium containing CEM/SIM 1, CEM/SIM 0.1, and CEM/SIM 0.01 were lower than the culture medium containing each of the materials alone (e.g., bioceramic cement or simvastatin 1 μM) (P < 0.0001, P < 0.0001, P < 0.0001, and P = 0.03, respectively).
Annexin V comparison graph. CEM: Bioceramic cement with full concentration; SIM 1: Simvastatin with concentration of 1 μM; SIM 0.1: Simvastatin with concentration of 0.1 μM; SIM 0.01: Simvastatin with concentration of 0.01 μM; CEM/SIM 1: Bioceramic cement containing simvastatin 1 μM; CEM/SIM 0.1: Bioceramic cement containing simvastatin 0.1 μM; CEM/SIM 0.01: Bioceramic cement containing simvastatin 0.01 μM
Evaluating biological effects is one of the most important aspects of dental material studies. Such substances can be clinically accepted if they do not show cytotoxicity in contact with oral tissues and do not cause irreversible inflammatory reactions by creating necrotic areas.
Studies on calcium silicate bioactive cements have shown
Few studies have evaluated the biocompatibility of bioceramic cements on pulp stem cells from primary teeth.
In this study, simvastatin was added to the bioceramic cement to benefit from its properties. In vitro studies have shown desirable properties of simvastatin, such as increased cell proliferation, odontoblastic differentiation, mineralization, and suppression of inflammation. This is the first time that simvastatin-induced cytotoxicity and induced apoptosis on SHED have been investigated. In previous studies, 5–40 mg per day has been recommended as the therapeutic dose of simvastatin. According to the 5% bioavailability of the drug, its systemic concentration has been estimated between 0.05 and 5 μM.
The results from the combination of the new bioceramic cement and simvastatin indicate that the concentration of simvastatin affects cytotoxicity and induced apoptosis. CEM/SIM 1 showed a decreasing trend in cell viability, although it was not statistically significant. In addition, the decrease in simvastatin concentration reversed the trend, and lower concentrations provided favorable conditions for cell proliferation. Also, it can be concluded that lower concentrations of simvastatin can reduce the apoptosis rate. It should not be overlooked that the presence of bioceramic cement in this compound could reduce the severity of the negative effects of simvastatin, especially at a concentration of 1 μM. In other words, each of the three compositions of bioceramic cements containing simvastatin showed significantly higher cell viability and lesser apoptosis compared to pure simvastatin at respective concentrations. For example, CEM/SIM 1 showed about 20% higher cell viability and 27% less apoptosis compared to SIM 1, respectively. This difference can be attributed to the presence of bioceramic cement as a biocompatible material that can improve the conditions of cell activity and survival in the presence of simvastatin by previously discussed properties. It should be noted that along with the reduced concentration of simvastatin in the cement, the abovementioned difference became less obvious, and cell viability took an upward trend. The bioceramic cements containing 0.1 μM and 0.01 μM simvastatin had significant superiority in terms of cell viability compared to MTA; however, as mentioned earlier, after the initial setting and along with the reduction of the acidity of the medium exposed to MTA, the cell viability increases.
Regarding concerns about the use of formocresol in pediatric dentistry and affordability of MTA, inexpensive biocompatible material with desirable biological properties might be considered as an alternative. The results of the present study are basic steps to evaluate the new material.
Considering the limitations of the study, it can be concluded that:
In the presence of the new bioceramic cement, the viability of SHED is not endangered. Moreover, this cement can provide an environment for cell proliferation Simvastatin at concentrations of 0.1 and 0.01 μM does not threaten cell viability and may even cause desirable biological properties that lead to cell proliferation Bioceramic cement containing 0.1 and 0.01 μM simvastatin has no toxic effect on SHED in comparison with MTA.
Financial support and sponsorship
The authors wish to acknowledge the financial support of the vice president of the Research Center of Mashhad University of Medical Sciences.
Conflicts of interest
The authors of this manuscript declare that they have no conflicts of interest, real or perceived, financial or nonfinancial in this article.